Qiagen NV (NYSE:QGEN)

48.90
Delayed Data
As of Nov 29
 +0.02 / +0.04%
Today’s Change
40.38
Today|||52-Week Range
56.21
-12.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$11.2B

Company Description

QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Contact Information

QIAGEN NV
Hulsterweg 82
Venlo Limburg 5912 PL
P:(177) 355-6600
Investor Relations:
(177) 355-6666

Employees

Shareholders

Mutual fund holders50.25%
Other institutional23.03%
Individual stakeholders--

Top Executives

Thierry BernardChief Executive Officer & Managing Director
Barthold PieningSenior Vice President & Head-Global Operations
Roland SackersChief Financial Officer & Managing Director
Lezette YoungManager-Compliance & Legal
Stephany FosterChief Human Resources Officer & Senior VP